Urothelial Dysfunction and Chronic Inflammation are Associated With Increased Bladder Sensation in Patients With Chronic Renal Insufficiency
Open Access
- 31 January 2018
- journal article
- research article
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 22 (Suppl 1) , S46-54
Abstract
Chronic kidney disease (CKD) or end-stage renal disease (ESRD) patients usually have lower urinary tract symptoms, such as frequency and urgency. Additionally, they frequently suffer from urinary tract infections. This study investigated dysfunction and chronic inflammation of the bladder urothelium in ESRD/CKD patients. This study enrolled 27 patients with CKD (n=13) or ESRD (n=14) for urodynamic studies and bladder biopsies. Patients presented with detrusor underactivity (DU; n=8) or bladder oversensitivity (BO; n=19). Bladder biopsies were performed in these patients and in 20 controls. The bladder mucosa was examined for E-cadherin and zonula occludens-1 (ZO-1) expression, activated mast cell count (through tryptase staining), and urothelial apoptosis (through terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling [TUNEL]). The urodynamic parameters were also compared with variables regarding urothelial dysfunction. The bladder mucosa samples of ESRD and CKD patients revealed significantly higher mast cell counts, more urothelial apoptosis, and lower levels of ZO-1 expression than the control samples. E-cadherin expression was significantly reduced in ESRD/CKD patients with DU, but not in ESRD/CKD patients with BO. Increased mast cell and apoptotic cell counts were also associated with ESRD/CKD with BO. Less expression of ZO-1 and E-cadherin was significantly associated with increased bladder sensation and a small bladder capacity. Bladder urothelial dysfunction and chronic inflammation were present to a noteworthy extent in patients with ESRD or CKD. Increased inflammation and defective barrier function were more notable in ESRD/CKD bladders with BO than in those with DU. The clinical characteristics of these patients may involve urothelial pathophysiology.Keywords
Funding Information
- Buddhist Compassion Relief Tzu Chi Foundation
This publication has 27 references indexed in Scilit:
- Increased Urothelial Cell Apoptosis and Chronic Inflammation Are Associated with Recurrent Urinary Tract Infection in WomenPLOS ONE, 2013
- The Mechanoreceptor TRPV4 is Localized in Adherence Junctions of the Human Bladder Urothelium: A Morphological StudyJournal of Urology, 2011
- Lower Urinary Tract Symptoms Are Frequent in Dialysis PatientsPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2011
- Higher levels of cell apoptosis and abnormal E‐cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndromeBJU International, 2010
- Bladder function of end‐stage renal disease patientsInternational Journal of Urology, 2010
- Abnormal Expression of Differentiation Related Proteins and Proteoglycan Core Proteins in the Urothelium of Patients With Interstitial CystitisJournal of Urology, 2008
- Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disordersNature Reviews Endocrinology, 2006
- Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal diseaseKidney International, 2005
- ABNORMAL EXPRESSION OF MOLECULAR MARKERS FOR BLADDER IMPERMEABILITY AND DIFFERENTIATION IN THE UROTHELIUM OF PATIENTS WITH INTERSTITIAL CYSTITISJournal of Urology, 2004
- THE ROLE OF BLADDER AFFERENT PATHWAYS IN BLADDER HYPERACTIVITY INDUCED BY THE INTRAVESICAL ADMINISTRATION OF NERVE GROWTH FACTORJournal of Urology, 2001